Functional analysis of the leukemia protein ELL: Evidence for a role in the regulation of cell growth and survival

Molecular and Cellular Biology

Volumn 21, Issue 5, 2001, Pages 1672-1681

  Johnstone, R W ^a   Gerber, M ^a   Landewe, T ^a   Tollefson, A ^a   Wold, W S ^a   Shilatifard, A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; COMPLEMENTARY RNA; DNA; GENE PRODUCT; LEUKEMIA PROTEIN ELL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL SURVIVAL; CHROMOSOME CONDENSATION; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, DIFFERENTIATION; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL CYCLE PROTEINS; CELL DEATH; CELL DIVISION; CELL LINE; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; DNA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; MITOSIS; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE ELONGATION FACTORS; PLASMIDS; POLY(ADP-RIBOSE) POLYMERASES; PROPIDIUM; PROTEINS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ELONGATION FACTORS; TRANSFECTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035134284     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.5.1672-1681.2001     Document Type: Article

References (56)

1. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins
2. Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293)
3. A novel gene, AF-1p, fused to HRX in t(1; 11)(p32; q23), is not related to AF-4, AF-9 nor ENL
4. Apoptosis induced by the histone deacerylase inhibitor sodium butyrate in human leukemic lymphoblasts
5. Interaction between dexamethasone and butyrate in apoptosis induction: Non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line
6. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins
7. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10; 11) translocation in acute leukemia
8. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes
9. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
10. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL
11. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis
12. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
13. The central executioners of apoptosis: Caspases or mitochondria?
14. The t(4; 11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorex, to the AF-4 gene
15. E1B 19,000-molecularweight protein interacts with and inhibits CED-4-dependent. FLICE-mediated apoptosis
16. Defects in yolk sac hematopoiesis in Mll-null embryos
17. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily
18. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13)
19. Acetylation of general transcription factors by histone acetyltransferases
20. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death
21. Overexpression of the MEN/ELL protein, an RNA polymerase II elongation factor, results in transformation of Rat1 cells with dependence on the lysine-rich region
22. Tumor antigens of human Ad5 in transformed cells and in cells infected with transformationdefective host-range mutants
23. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice
24. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL
25. Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia
26. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription
27. t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes
28. Potential role for wild-type p53 in leukemias with MLL gene translocations
29. Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3
30. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
31. Apoptosis by death factor
32. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs
33. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11; 17)(q23; q25)
34. Cloning and characterization of the t(X; 11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family
35. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE
36. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation
37. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia
38. Backtracking leukemia to birth
39. The critical role of chromosome translocations in human leukemias
40. ENL, the gene fused with HRX in t(11; 19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells
41. An RNA polymerase II elongation factor encoded by the human ELL gene
42. Structure and function of RNA polymerase II elongation factor ELL: Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary, elongation complex
43. Factors regulating the transcriptional elongation activity of RNA polymerase II
44. Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53
45. The role of TNF in lymphocyte-mediated cytotoxicity
46. EEN encodes a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia
47. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11; 16)(q23; p13.3)
48. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10; 11)(p11.2; q23)
49. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
50. Cloning of ELL, a gene that fuses to MLL in a t(11; 19)(q23; p13.1) in acute myeloid leukemia
51. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
52. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells
53. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
54. Adenovirus proteins that regulate apoptosis
55. Altered Hox expression and segmental identity in Mll-mutant mice
56. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis